{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:43:19Z","timestamp":1791614599874,"version":"4.3.4"},"reference-count":120,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH-NHLBI","award":["2R15HL143545-02"],"award-info":[{"award-number":["2R15HL143545-02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: HIV and tuberculosis (TB) co-infection poses a significant health challenge, particularly when involving the central nervous system (CNS), where it leads to severe morbidity and mortality. Current treatments face challenges such as drug resistance, immune reconstitution inflammatory syndrome (IRIS), and persistent inflammation. Glutathione (GSH) has the therapeutic potential to enhance treatment outcomes by improving antibiotic efficacy, reducing inflammation, and mitigating immune dysfunction. Methods: Relevant studies were identified through systematic searches of PubMed, Elsevier, WHO, and related databases. Inclusion criteria focused on preclinical and clinical research examining GSH or its precursors in HIV, TB, or co-infection, with emphasis on microbial control, immune modulation, and CNS-related outcomes. Results: Preclinical studies showed that GSH improves macrophage antimicrobial function, reduces oxidative stress, and limits Mycobacterium tuberculosis (M.tb) growth. Animal models demonstrated reduced bacterial burden in the lungs, liver, and spleen with GSH supplementation, along with enhanced granuloma stability. Clinical studies highlighted increased TH1 cytokine production, reduced inflammatory markers, and improved CD4+ T cell counts in HIV\u2013M.tb co-infected patients. N-acetylcysteine (NAC), a GSH precursor, was shown to significantly enhance the efficacy of first-line TB antibiotics and mitigate treatment-associated toxicity. Discussion: GSH shows promise as an adjunct therapy for HIV\u2013M.tb co-infection, particularly for cases involving the CNS, where it may improve immune recovery and reduce inflammation. However, evidence is limited by small sample sizes and a lack of randomized trials. Future research should focus on developing CNS-directed GSH formulations and evaluating its integration into current treatment protocols to address the dual burden of HIV and TB, ultimately improving patient outcomes.<\/jats:p>","DOI":"10.3390\/v17010127","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T03:33:02Z","timestamp":1737084782000},"page":"127","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Additive Effects of Glutathione in Improving Antibiotic Efficacy in HIV\u2013M.tb Co-Infection in the Central Nervous System: A Systematic Review"],"prefix":"10.3390","volume":"17","author":[{"given":"Leena","family":"Nabipur","sequence":"first","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mouawad","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-1160","authenticated-orcid":false,"given":"Vishwanath","family":"Venketaraman","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024, December 22). HIV\/AIDS. Published 30 November 2023. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids."},{"key":"ref_2","unstructured":"World Health Organization (2024, December 22). Tuberculosis. Published 10 October 2023. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","article-title":"The paradox of HIV blood\u2013brain barrier penetrance and antiretroviral drug delivery deficiencies","volume":"43","author":"Osborne","year":"2020","journal-title":"Trends Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wong, K., Nguyen, J., Blair, L., Banjanin, M., Grewal, B., Bowman, S., Boyd, H., Gerstner, G., Cho, H.J., and Panfilov, D. (2020). Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113575"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.bbagen.2012.10.012","article-title":"Glutathione and infection","volume":"1830","author":"Morris","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2018.08.001","article-title":"Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination","volume":"24","author":"Cohen","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Navasardyan, I., Abdou, A., Kades, S., Misakyan, Y., Ochsner, J., Subbian, S., and Venketaraman, V. (2023). Tuberculosis meningitis coexisting with HIV Infection: A comprehensive review. Front. Tuberc., 1.","DOI":"10.3389\/ftubr.2023.1242869"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder\u2014Pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/IAI.73.3.1886-1889.2005","article-title":"Glutathione and nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis","volume":"73","author":"Venketaraman","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Silvagno, F., Vernone, A., and Pescarmona, G.P. (2020). The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19. Antioxidants, 9.","DOI":"10.3390\/antiox9070624"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.ircmb.2021.01.001","article-title":"Ca2+ homeostasis in brain microvascular endothelial cells","volume":"362","author":"Stoica","year":"2021","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6564585","DOI":"10.1155\/2021\/6564585","article-title":"Blood-Brain Barrier Overview: Structural and Functional Correlation","volume":"2021","author":"Alahmari","year":"2021","journal-title":"Neural Plast."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1007\/s12035-022-02890-8","article-title":"HIV Promotes Neurocognitive Impairment by Damaging the Hippocampal Microvessels","volume":"59","author":"Sharma","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Tang, X., Lu, H., and Ramratnam, B. (2020). Neurotoxicity of HIV-1 Tat is attributed to its penetrating property. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-70950-x"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s13365-023-01179-3","article-title":"Disruption of blood-brain barrier: Effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins","volume":"29","author":"Sun","year":"2023","journal-title":"J. Neurovirol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/s41467-020-15844-2","article-title":"The UPR sensor IRE1\u03b1 and the adenovirus E3-19K glycoprotein sustain persistent and lytic infections","volume":"11","author":"Prasad","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1007\/s00018-020-03561-4","article-title":"Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND","volume":"77","author":"Marino","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2011.05.015","article-title":"Breaking down the barrier: The effects of HIV-1 on the blood-brain barrier","volume":"1399","author":"Strazza","year":"2011","journal-title":"Brain Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rivera, J., Isidro, R.A., Loucil-Alicea, R.Y., Cruz, M.L., Appleyard, C.B., Isidro, A.A., Chompre, G., Colon-Rivera, K., and Noel, R.J. (2019). Infusion of HIV-1 Nef-expressing astrocytes into the rat hippocampus induces enteropathy and interstitial pneumonitis and increases blood-brain-barrier permeability. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225760"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s11010-021-04056-x","article-title":"Rho-kinase inhibitor hydroxyfasudil protects against HIV-1 Tat-induced dysfunction of tight junction and neprilysin\/A\u03b2 transfer receptor expression in mouse brain microvessels","volume":"476","author":"Chen","year":"2021","journal-title":"Mol. Cell Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1748983","DOI":"10.1080\/21688370.2020.1748983","article-title":"HIV Tat-mediated induction of autophagy regulates the disruption of ZO-1 in brain endothelial cells","volume":"8","author":"Liao","year":"2020","journal-title":"Tissue Barriers"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bhalerao, A., and Cucullo, L. (2022). HIV-1 gp120 and tobacco smoke synergistically disrupt the integrity of the blood-brain barrier. Eur. J. Cell Biol., 101.","DOI":"10.1016\/j.ejcb.2022.151271"},{"key":"ref_24","unstructured":"Vohra, S., and Dhaliwal, H.S. (2024). Miliary Tuberculosis. StatPearls, StatPearls Publishing."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11910-022-01173-y","article-title":"Granulomatous diseases of the central nervous system","volume":"22","author":"Dasovic","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00062-018-0726-9","article-title":"Central Nervous System Tuberculosis: Etiology, Clinical Manifestations and Neuroradiological Features","volume":"29","author":"Schaller","year":"2019","journal-title":"Clin. Neuroradiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/JLB.MR0318-102R","article-title":"The pathogenesis of tuberculous meningitis","volume":"105","author":"Davis","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Renault, C., Veyrenche, N., Mennechet, F., Bedin, A.S., Routy, J.P., Van de Perre, P., Reynes, J., and Tuaillon, E. (2022). Th17 CD4+ T-Cell as a Preferential Target for HIV Reservoirs. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.822576"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Xiao, T., Cai, Y., and Chen, B. (2021). HIV-1 Entry and Membrane Fusion Inhibitors. Viruses, 13.","DOI":"10.3390\/v13050735"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s12551-022-00999-7","article-title":"Membrane attachment and fusion of HIV-1, influenza A, and SARS-CoV-2: Resolving the mechanisms with biophysical methods","volume":"14","author":"Negi","year":"2022","journal-title":"Biophys. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hosseinian, K., Gerami, A., Bral, M., and Venketaraman, V. (2024). Mycobacterium tuberculosis-Human Immunodeficiency Virus Infection and the Role of T Cells in Protection. Vaccines, 12.","DOI":"10.3390\/vaccines12070730"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e0101122","DOI":"10.1128\/jvi.01011-22","article-title":"HIV-1 Preintegration Complex Preferentially Integrates the Viral DNA into Nucleosomes Containing Trimethylated Histone 3-Lysine 36 Modification and Flanking Linker DNA","volume":"96","author":"Sapp","year":"2022","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Masenga, S.K., Mweene, B.C., Luwaya, E., Muchaili, L., Chona, M., and Kirabo, A. (2023). HIV-Host Cell Interactions. Cells, 12.","DOI":"10.3390\/cells12101351"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Shcherbatova, O., Grebennikov, D., Sazonov, I., Meyerhans, A., and Bocharov, G. (2020). Modeling of the HIV-1 Life Cycle in Productively Infected Cells to Predict Novel Therapeutic Targets. Pathogens, 9.","DOI":"10.3390\/pathogens9040255"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Elliott, J.L., and Kutluay, S.B. (2020). Going beyond Integration: The Emerging Role of HIV-1 Integrase in Virion Morphogenesis. Viruses, 12.","DOI":"10.3390\/v12091005"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cao, D., Khanal, S., Wang, L., Li, Z., Zhao, J., Nguyen, L.N., Nguyen, L.N., Dang, X., Schank, M., and Thakuri, B.K. (2021). A Matter of Life or Death: Productively Infected and Bystander CD4 T Cells in Early HIV Infection. Front. Immunol., 11, Correction in Front. Immunol. 2022, 13, 937057.","DOI":"10.3389\/fimmu.2022.937057"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Yaseen, M.M., Abuharfeil, N.M., and Darmani, H. (2022). T-cell evasion and invasion during HIV-1 infection: The role of HIV-1 Tat protein. Cell. Immunobiol., 377.","DOI":"10.1016\/j.cellimm.2022.104554"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ajasin, D., and Eugenin, E.A. (2020). HIV-1 Tat: Role in bystander toxicity. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00061"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e01436-18","DOI":"10.1128\/JVI.01436-18","article-title":"Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers","volume":"93","author":"Llano","year":"2019","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Woottum, M., Yan, S., Sayettat, S., Grinberg, S., Cathelin, D., Bekaddour, N., Herbeuval, J.-P., and Benichou, S. (2024). Macrophages: Key Cellular Players in HIV Infection and Pathogenesis. Viruses, 16.","DOI":"10.3390\/v16020288"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Chitrakar, A., Sanz, M., Maggirwar, S.B., and Soriano-Sarabia, N. (2022). HIV Latency in Myeloid Cells: Challenges for a Cure. Pathogens, 11.","DOI":"10.3390\/pathogens11060611"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev-pathol-042120-032916","article-title":"Perspectives and advances in the understanding of tuberculosis","volume":"16","author":"Kinsella","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.chom.2021.02.005","article-title":"TGF\u03b2 restricts expansion, survival, and function of T cells within the tuberculous granuloma","volume":"29","author":"Gern","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1601340","article-title":"T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection","volume":"199","author":"Redford","year":"2017","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41589-019-0336-0","article-title":"Mycobacterium tuberculosis releases an antacid that remodels phagosomes","volume":"15","author":"Buter","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"eaaw6693","DOI":"10.1126\/sciimmunol.aaw6693","article-title":"Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo","volume":"4","author":"Rothchild","year":"2019","journal-title":"Sci. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.celrep.2019.12.033","article-title":"Dual RNA-Seq of Mtb-Infected Macrophages In Vivo Reveals Ontologically Distinct Host-Pathogen Interactions","volume":"30","author":"Pisu","year":"2020","journal-title":"Cell Rep."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Saini, N.K., Baena, A., Ng, T.W., Venkataswamy, M.M., Kennedy, S.C., Kunnath-Velayudhan, S., Carre\u00f1o, L.J., Xu, J., Chan, J., and Larsen, M.H. (2016). Suppression of autophagy and antigen presentation by Mycobacterium tuberculosis PE_PGRS47. Nat. Microbiol., 1.","DOI":"10.1038\/nmicrobiol.2016.133"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4049\/jimmunol.1801143","article-title":"Mycobacterium tuberculosis PPE2 Protein Interacts with p67phox and Inhibits Reactive Oxygen Species Production","volume":"203","author":"Srivastava","year":"2019","journal-title":"J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e52175","DOI":"10.15252\/embr.202052175","article-title":"Mycobacterium tuberculosis protein kinase G acts as an unusual ubiquitinating enzyme to impair host immunity","volume":"22","author":"Wang","year":"2021","journal-title":"EMBO Rep."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zenebe, Y., Necho, M., Yimam, W., and Akele, B. (2022). Worldwide Occurrence of HIV-Associated Neurocognitive Disorders and Its Associated Factors: A Systematic Review and Meta-Analysis. Front. Psychiatry, 13.","DOI":"10.3389\/fpsyt.2022.814362"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Rojas-Celis, V., Valiente-Echeverr\u00eda, F., Toro-Ascuy, D., and Soto-Rifo, R. (2019). New Challenges of HIV-1 Infection: How HIV-1 Attacks and Resides in the Central Nervous System. Cells, 8.","DOI":"10.3390\/cells8101245"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.2147\/IJGM.S295859","article-title":"HIV-Associated Neurocognitive Disorder (HAND): Obstacles to Early Neuropsychological Diagnosis","volume":"15","author":"Vastag","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.3390\/cimb46060330","article-title":"Glutathione in HIV-Associated Neurocognitive Disorders","volume":"46","author":"Erdos","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/1570162X16666181003144740","article-title":"HIV associated neurodegenerative disorders: A new perspective on the role of lipid rafts in Gp120-mediated neurotoxicity","volume":"16","author":"Smith","year":"2018","journal-title":"Curr. HIV Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1267041","DOI":"10.1155\/2021\/1267041","article-title":"HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins","volume":"2021","author":"Jadhav","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.virol.2007.02.004","article-title":"Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: Mechanistic and therapeutic implications","volume":"363","author":"Agrawal","year":"2007","journal-title":"Virology"},{"key":"ref_59","unstructured":"Gupta, M., Tobin, E.H., and Munakomi, S. (2024, December 13). CNS Tuberculosis. [Updated 2024 May 6], StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585138\/."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijtb.2017.05.011","article-title":"Spectrum of central nervous system tuberculosis: An experience from a large tertiary care institution of India","volume":"66","author":"Ingole","year":"2019","journal-title":"Indian J. Tuberc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/CON.0000000000001005","article-title":"Neurologic Complications of Tuberculosis","volume":"27","author":"Saylor","year":"2021","journal-title":"CONTINUUM Lifelong Learn. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clinimag.2020.07.020","article-title":"Central nervous system and spinal cord tuberculosis: Revisiting an important disease","volume":"69","author":"Salvador","year":"2020","journal-title":"Clin. Imaging"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Chen, T.H., Wang, H.C., Chang, C.J., and Lee, S.Y. (2024). Mitochondrial Glutathione in Cellular Redox Homeostasis and Disease Manifestation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021314"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Moule, M.G., and Cirillo, J.D. (2020). Mycobacterium tuberculosis Dissemination Plays a Critical Role in Pathogenesis. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00065"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","article-title":"Glutathione","volume":"52","author":"Meister","year":"1983","journal-title":"Annu. Rev. Biochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.6836290","article-title":"Selective modification of glutathione metabolism","volume":"220","author":"Meister","year":"1983","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1073\/pnas.80.3.707","article-title":"Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis","volume":"80","author":"Anderson","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_69","first-page":"12500","article-title":"Could glutathione depletion be the Trojan horse of COVID-19 mortality?","volume":"24","author":"Khanfar","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/acsinfecdis.0c00288","article-title":"Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients","volume":"6","author":"Polonikov","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.vh.2022.09.002","article-title":"The antioxidant glutathione","volume":"121","year":"2023","journal-title":"Vitam. Horm."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s001099900073","article-title":"Improvement of immune functions in HIV infection by sulfur supplementation: Two randomized trials","volume":"78","author":"Breitkreutz","year":"2000","journal-title":"J. Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Va\u0161kov\u00e1, J., Ko\u010dan, L., Va\u0161ko, L., and Perj\u00e9si, P. (2023). Glutathione-Related Enzymes and Proteins: A Review. Molecules, 28.","DOI":"10.3390\/molecules28031447"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Abrahem, R., Chiang, E., Haquang, J., Nham, A., Ting, Y.S., and Venketaraman, V. (2020). The Role of Dendritic Cells in TB and HIV Infection. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082661"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1128\/IAI.69.3.1755-1765.2001","article-title":"Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms","volume":"69","author":"Brill","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"41525","DOI":"10.1074\/jbc.M110.189944","article-title":"Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells","volume":"285","author":"Yan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.162.5.2569","article-title":"N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: Association with NF-kappaB inhibition","volume":"162","author":"Verhasselt","year":"1999","journal-title":"J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbacli.2016.05.006","article-title":"Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer\u2019s disease and its implication in the pathophysiology of the disease process","volume":"6","author":"Saing","year":"2016","journal-title":"BBA Clin."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"734125","DOI":"10.1155\/2012\/734125","article-title":"Unveiling the mechanisms for decreased glutathione in individuals with HIV infection","volume":"2012","author":"Morris","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Coco-Bassey, S.B., Asemota, E.A., Okoroiwu, H.U., Etura, J.E., Efiong, E.E., Inyang, I.J., and Uko, E.K. (2019). Glutathione, Glutathione Peroxidase and Some Hematological Parameters of HIV-Seropositive Subjects Attending Clinic in University of Calabar Teaching Hospital, Calabar, Nigeria. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4562-6"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.175.4.1111","article-title":"Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages","volume":"175","author":"Chan","year":"1992","journal-title":"J. Exp. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.4049\/jimmunol.138.12.4408","article-title":"Mycobacterial growth inhibition by interferon-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis","volume":"138","author":"Flesch","year":"1987","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/IAI.66.11.5314-5321.1998","article-title":"1,25-Dihydroxyvitamin-D3 induces nitric oxide and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line","volume":"66","author":"Rockett","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4049\/jimmunol.160.3.1290","article-title":"Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages","volume":"160","author":"Schaible","year":"1998","journal-title":"J. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/IAI.68.2.429-436.2000","article-title":"A peptide permease mutant of Mycobacterium bovis BCG resistant to the toxic peptides glutathione and S-nitrosoglutathione","volume":"68","author":"Green","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"30391","DOI":"10.1074\/jbc.273.46.30391","article-title":"Micothiol biosynthesis and metabolism; Cellular levels of potential intermediates in the biosynthesis and degredation of mycothiol in Mycobacterium smegmatis","volume":"273","author":"Anderberg","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2249.2011.04552.x","article-title":"Control of Mycobacterium tuberculosis growth by activated natural killer cells","volume":"168","author":"Guerra","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/jir.2007.0095","article-title":"Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis","volume":"28","author":"Millman","year":"2008","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Guerra, C., Morris, D., Sipin, A., Kung, S., Franklin, M., Gray, D., Tanzil, M., Guilford, F., Khasawneh, F.T., and Venketaraman, V. (2011). Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028378"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1309\/Q49CRJ030L22MHLF","article-title":"The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders","volume":"127","author":"Morice","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Bonetti, L., Horkova, V., Longworth, J., Guerra, L., Kurniawan, H., Franchina, D.G., Soriano-Baguet, L., Grusdat, M., Spath, S., and Koncina, E. (2023). A Th17 Cell-Intrinsic Glutathione\/Mitochondrial-IL-22 Axis Protects against Intestinal Inflammation. bioRxiv.","DOI":"10.1101\/2023.07.06.547932"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/425742","article-title":"Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy","volume":"39","author":"Breton","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.0804020","article-title":"Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative \u03b3\u03b4 T cells","volume":"183","author":"Bourgarit","year":"2009","journal-title":"J. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.168.7.3451","article-title":"The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium","volume":"168","author":"Vankalayapati","year":"2002","journal-title":"J. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.4049\/jimmunol.173.12.7490","article-title":"IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice","volume":"173","author":"Pearl","year":"2004","journal-title":"J. Immunol."},{"key":"ref_98","first-page":"71","article-title":"Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease","volume":"6","author":"Olalla","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.162.1.97","article-title":"Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy","volume":"162","author":"Navas","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"ref_100","first-page":"1053","article-title":"Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis","volume":"38","author":"Tansuphasawadikul","year":"2007","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/jir.2014.0210","article-title":"Liposomal glutathione supplementation restores TH1 cytokine response to Mycobacterium tuberculosis infection in HIV-infected individuals","volume":"35","author":"Ly","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jinf.2006.01.002","article-title":"Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy","volume":"53","author":"Manosuthi","year":"2006","journal-title":"J. Infect."},{"key":"ref_103","first-page":"1282","article-title":"Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis","volume":"11","author":"Burman","year":"2007","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0300-483X(96)03520-2","article-title":"Immunomodulatory and protective effects of N-acetylcysteine in mitogen-activated murine splenocytes in vitro","volume":"116","author":"Omara","year":"1997","journal-title":"Toxicology"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Tieu, S., Charchoglyan, A., Paulsen, L., Wagter-Lesperance, L.C., Shandilya, U.K., Bridle, B.W., Mallard, B.A., and Karrow, N.A. (2023). N-Acetylcysteine and its immunomodulatory properties in humans and domesticated animals. Antioxidants, 12.","DOI":"10.3390\/antiox12101867"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e01132-18","DOI":"10.1128\/AAC.01132-18","article-title":"Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis","volume":"62","author":"Cao","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e155851","DOI":"10.1172\/JCI155851","article-title":"High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis","volume":"132","author":"Mota","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"100252","DOI":"10.1016\/j.jctube.2021.100252","article-title":"Central Nervous System Tuberculosis (CNS-TB) in treated HIV-infected adults in Tikur Anbessa Specialized Hospital, Ethiopia: A cross sectional study","volume":"24","author":"Ayele","year":"2021","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"969","DOI":"10.5588\/ijtld.15.0123","article-title":"Treatment outcomes for HIV and MDR-TB co-infected adults and children: Systematic review and meta-analysis","volume":"19","author":"Isaakidis","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","article-title":"Treatment of drug-resistant tuberculosis. An official ATS\/CDC\/ERS\/IDSA clinical practice guideline","volume":"200","author":"Nahid","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e00141-20","DOI":"10.1128\/CMR.00141-20","article-title":"Mechanisms of drug-induced tolerance in mycobacterium tuberculosis","volume":"34","author":"Goossens","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Teskey, G., Cao, R., Islamoglu, H., Medina, A., Prasad, C., Prasad, R., Sathananthan, A., Fraix, M., Subbian, S., and Zhong, L. (2018). The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02069"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Sasaninia, K., Kelley, M., Abnousian, A., Owens, J., Yoon, S., Beever, A., Kachour, N., Yegiazaryan, A., Kolloli, A., and Kumar, R. (2023). Liposomal glutathione supplementation mitigates extrapulmonary tuberculosis in the liver and spleen. Front. Biosci.-Elite, 15.","DOI":"10.31083\/j.fbe1503015"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Kachour, N., Beever, A., Owens, J., Cao, R., Kolloli, A., Kumar, R., Sasaninia, K., Vaughn, C., Singh, M., and Truong, E. (2022). Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs. Antioxidants, 11.","DOI":"10.3390\/antiox11040673"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Cao, R., Kolloli, A., Kumar, R., Owens, J., Sasaninia, K., Vaughn, C., Singh, M., Truong, E., Kachour, N., and Beever, A. (2021). Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection. Appl. Sci., 11.","DOI":"10.3390\/app11178274"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Kenchappa, V., Cao, R., Venketaraman, V., and Betageri, G.V. (2022). Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione\u2014An Approach to Combat Opportunistic Infections. Appl. Sci., 12.","DOI":"10.3390\/app12031468"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1089\/aid.2016.0303","article-title":"Restoring cytokine balance in HIV-positive individuals with low CD4 T cell counts","volume":"33","author":"Valdivia","year":"2017","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Safe, I.P., Lacerda, M.V., Printes, V.S., Praia Marins, A.F., Rebelo Rabelo, A.L., Costa, A.A., Tavares, M.A., Jesus, J.S., Souza, A.B., and Beraldi-Magalh\u00e3es, F. (2020). Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study). PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0235381"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Tuell, D., Ford, G., Los, E., and Stone, W. (2024). The Role of Glutathione and Its Precursors in Type 2 Diabetes. Antioxidants, 13.","DOI":"10.3390\/antiox13020184"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Page, M.J., McKenzie, J.E., Bossuyt, P.M., Boutron, I., Hoffmann, T.C., Mulrow, C.D., Shamseer, L., Tetzlaff, J.M., Akl, E.A., and Brennan, S.E. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372.","DOI":"10.1136\/bmj.n71"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/1\/127\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:30:24Z","timestamp":1759919424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/1\/127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["v17010127"],"URL":"https:\/\/doi.org\/10.3390\/v17010127","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}